retatrutide obesity clinical trial results data trials The Effect of Retatrutide on Kidney Parameters in Participants With Type 2 Diabetes Mellitus and/or retatrutide clinical trials results What

This screening is a fundamental safety measure and should be documented in the patient's medical records

No employer drug plan

(2023) 2:e103

Accepted: Published: Version of record: Issue date: DOI:

While GLP-1 agonists, particularly those prescribed under the brand names Ozempic, Wegovy, and Mounjaro, have become wildly popular for treating type 2 diabetes and obesity, scientists are just beginning to piece together the effects these medications may have on the brain

When cagrilintide is paired with semaglutide as CagriSema, the gap narrows23% for CagriSema versus 25.5% for Zepbound in a direct head-to-head trialbut Zepbound still holds a modest edge